Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage.

Searle E, Pavord S, Alfirevic Z.

Best Pract Res Clin Obstet Gynaecol. 2008 Dec;22(6):1075-88. doi: 10.1016/j.bpobgyn.2008.08.010. Epub 2008 Oct 1.

PMID:
18838340
2.

Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage.

Mercier FJ, Bonnet MP.

Curr Opin Anaesthesiol. 2010 Jun;23(3):310-6. doi: 10.1097/ACO.0b013e32833835a2. Review.

PMID:
20216063
3.

The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.

Wissa I, Ebeid E, El-Shawarby S, Chandakas S, Kamal T, Hill N.

J Obstet Gynaecol. 2009 Jan;29(1):21-4. doi: 10.1080/01443610802628692. Review.

PMID:
19280490
4.

Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery.

Ekelund K, Hanke G, Stensballe J, Wikkelsøe A, Albrechtsen CK, Afshari A.

Acta Obstet Gynecol Scand. 2015 Jul;94(7):680-92. doi: 10.1111/aogs.12607. Epub 2015 Mar 5. Review.

PMID:
25660118
5.

Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study.

Barillari G, Frigo MG, Casarotto M, Farnia A, Massè B, Wetzl R, Bianchin A, Rabi A, Malacarne P, Pasca S, Bigotto E; Italian rFVIIa-PPH Study Group.

Thromb Res. 2009 Dec;124(6):e41-7. doi: 10.1016/j.thromres.2009.08.018. Epub 2009 Sep 24.

PMID:
19783283
6.

Use of recombinant factor VIIa in massive post-partum haemorrhage.

McMorrow RC, Ryan SM, Blunnie WP, Bowen M, Carton EG, Gardiner J, Geary M, Loughrey JP.

Eur J Anaesthesiol. 2008 Apr;25(4):293-8. doi: 10.1017/S0265021507003109. Epub 2008 Jan 7.

PMID:
18177539
7.

[Transfusion for post-partum haemorrhage: what's new in 2011?].

Bonnet MP, Tesnière A, Mignon A.

Transfus Clin Biol. 2011 Apr;18(2):129-32. doi: 10.1016/j.tracli.2011.02.011. Epub 2011 Mar 21. Review. French.

PMID:
21420343
8.

Postpartum hemorrhage in a Jehovah's Witness patient controlled with Tisseel, tranexamic acid, and recombinant factor VIIa.

Arab TS, Al-Wazzan AB, Maslow K.

J Obstet Gynaecol Can. 2010 Oct;32(10):984-7.

PMID:
21176309
9.

[Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].

Mostić T, Sparić R, Argirović R, Ljubić A, Bozanović T, Arsenijević L, Tomanović-Koković J, Stefanović A.

Srp Arh Celok Lek. 2008 Sep;136 Suppl 3:204-9. Serbian.

10.

[Recombinant factor VII-a--new possibility for the treatment of severe postpartal bleeding--literature review].

Katsulov A, Getskovski T, Iankov M, Kirova N.

Akush Ginekol (Sofiia). 2004;43(5):44-6. Review. Bulgarian. No abstract available.

PMID:
15518285
11.

Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.

Nicklin J, Perrin L, Crandon A, Land R, Nascimento M, Obermair A.

Aust N Z J Obstet Gynaecol. 2008 Aug;48(4):447. doi: 10.1111/j.1479-828X.2008.00897.x. No abstract available.

PMID:
18837857
12.

Guidelines for use of recombinant factor VIIa in life-threatening post-partum haemorrhage.

Duffy MR.

Int J Obstet Anesth. 2007 Jul;16(3):299-300; author reply 300. Epub 2007 May 16. No abstract available.

PMID:
17509865
13.

Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial.

Aawar N, Alikhan R, Bruynseels D, Cannings-John R, Collis R, Dick J, Elton C, Fernando R, Hall J, Hood K, Lack N, Mallaiah S, Maybury H, Nuttall J, Paranjothy S, Rayment R, Rees A, Sanders J, Townson J, Weeks A, Collins P.

Trials. 2015 Apr 17;16:169. doi: 10.1186/s13063-015-0670-9.

14.

A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.

Franchini M, Franchi M, Bergamini V, Salvagno GL, Montagnana M, Lippi G.

Semin Thromb Hemost. 2008 Feb;34(1):104-12. doi: 10.1055/s-2008-1066022. Review.

PMID:
18393147
15.

Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.

Sobieszczyk S, Breborowicz GH, Platicanov V, Tanchev S, Kessler CM.

Acta Obstet Gynecol Scand. 2006;85(10):1239-47. Review.

PMID:
17068684
16.

[Recombinant activated factor VII as a life-saving therapy for severe postpartum haemorrhage unresponsive to conservative traditional management].

Brice A, Hilbert U, Roger-Christoph S, Fernandez H, Dumenil AS, Descorps-Declère A, Mercier F, Benhamou D.

Ann Fr Anesth Reanim. 2004 Nov;23(11):1084-8. French.

PMID:
15581725
17.

Prohemostatic interventions in obstetric hemorrhage.

Bonnet MP, Basso O.

Semin Thromb Hemost. 2012 Apr;38(3):259-64. doi: 10.1055/s-0032-1302441. Epub 2012 Feb 18. Review.

PMID:
22510859
18.

Massive postpartum hemorrhage: recombinant factor VIIa use is safe but not effective.

Kalina M, Tinkoff G, Fulda G.

Del Med J. 2011 Apr;83(4):109-13.

PMID:
21675158
19.

The use of recombinant activated FVII in postpartum hemorrhage.

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Clin Obstet Gynecol. 2010 Mar;53(1):219-27. doi: 10.1097/GRF.0b013e3181cc4378. Review.

PMID:
20142658
20.

Massive transfusion and nonsurgical hemostatic agents.

Perkins JG, Cap AP, Weiss BM, Reid TJ, Bolan CD.

Crit Care Med. 2008 Jul;36(7 Suppl):S325-39. doi: 10.1097/CCM.0b013e31817e2ec5. Review. Erratum in: Crit Care Med. 2008 Sep;36(9):2718. Bolan, Charles E [corrected to Bolan, Charles D].

PMID:
18594260

Supplemental Content

Support Center